Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2008
10/02/2008CA2681775A1 A vaccine preventing and/or treating autoimmune diseases
10/02/2008CA2681741A1 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof
10/02/2008CA2681570A1 Shortened purification process for the production of capsularstreptococcus pneumoniae polysaccharides
10/02/2008CA2681567A1 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
10/02/2008CA2681531A1 Immunoglobulin heavy chains comprising heterologous t-cell epitopes
10/02/2008CA2681530A1 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof
10/02/2008CA2681144A1 Cancer disease modifying antibody 010207-01 produced by hybridoma cell line ar51a630.3.
10/02/2008CA2681132A1 Prame derived peptides and immunogenic compositions comprising these
10/02/2008CA2680093A1 Synbiotic to improve gut microbiota
10/02/2008CA2680046A1 Methods of diagnosing, classifying and treating endometrial cancer and precancer
10/02/2008CA2679332A1 Polypeptide recognized by anti hiv-1 gp41 antibodies isolated from highly hiv-1 exposed, non infected women
10/02/2008CA2679081A1 Probiotics to reduce episodes of diarrhoea in infants born by caesarean section
10/02/2008CA2678698A1 Use of an avirulent bordetella mutant as a live vaccine vector
10/02/2008CA2676842A1 Methods of releasing sporocysts from oocysts using controlled shear forces
10/01/2008EP1975235A2 Porcine circovirus vaccine in recombinant poxvirus
10/01/2008EP1975231A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/01/2008EP1975183A1 Tumour-specific recognition molecules
10/01/2008EP1975182A1 CD40-binding APC-activating molecules
10/01/2008EP1975181A1 Use of vascular endothelial cell growth factor antagonists
10/01/2008EP1975180A1 Treatment of autoimmune diseases with antibody anti gamma interferon
10/01/2008EP1975173A1 Anti-Retroviral Immunogens, Preparation and Use
10/01/2008EP1974750A1 Preventive or therapeutic agent and method for immune disease
10/01/2008EP1974749A1 Cripto blocking antibodies and uses thereof
10/01/2008EP1974748A2 Antibodies for the diagnosis of diseases associated with fibrosis
10/01/2008EP1974747A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
10/01/2008EP1974746A2 Use of an adjuvanted allergy vaccine formulation for parenteral administration
10/01/2008EP1974745A1 Use of an adjuvanted allergy vaccine formulation for parenteral administration
10/01/2008EP1974744A1 Immunization through oral administration of a vaccine with an edible product
10/01/2008EP1974743A1 Probiotics to Improve Gut Microbiota
10/01/2008EP1974742A1 A method for improving the manufacturing process of a tumour vaccine
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974723A2 Secure forms of anti-EGFR antibodies
10/01/2008EP1974217A2 Method for the in vitro diagnosis of chlamydophila pneumoniae infections
10/01/2008EP1974048A1 Method for preparing antibodies selective for activating fc receptors
10/01/2008EP1974023A1 Dengue chimeric viruses
10/01/2008EP1974021A1 Maturation of dendritic cells.
10/01/2008EP1973950A2 Anti-ephb4 antibodies and methods using same
10/01/2008EP1973933A1 A NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2008EP1973931A2 Chicken virus vaccine and diagnostic
10/01/2008EP1973608A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
10/01/2008EP1973568A1 Cytotoxic antibodies targeting antibodies inhibiting factor viii
10/01/2008EP1973567A1 Hypoallergenic variants of the major allergen from betula verrucosa pollen
10/01/2008EP1973566A1 An adjuvant system comprising virosomes and liposomes
10/01/2008EP1973565A2 Marked bovine viral diarrhea virus vaccines
10/01/2008EP1973564A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
10/01/2008EP1528914B1 Antigenic compositions
10/01/2008EP1390397B1 Pre-s protein of hepatitis b virus (hbv) as an adjuvant and a component of hbv vaccine
10/01/2008EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
10/01/2008CN101278057A Cancerous disease modifying antibodies
10/01/2008CN101278056A Cancerous disease modifying antibodies
10/01/2008CN101278055A Cancerous disease modifying antibodies
10/01/2008CN101278043A Chimeric empty viral-like particles derived from the infectious bursal disease virus (IDBV), process for their production and applications
10/01/2008CN101278041A Genes from actinobacillus succinogenes 13oz (atcc 55618) for production of chemicals from the a. succinogenes C4-pathway
10/01/2008CN101277977A Cancerous disease modifying antibodies
10/01/2008CN101277976A Anti-myostatin antibodies
10/01/2008CN101277974A Binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and their use
10/01/2008CN101277971A Vaccines against AIDS comprising CMV/R - nucleic acid constructs
10/01/2008CN101277722A Composition and method for prevention and treatment of type I diabetes
10/01/2008CN101277718A Molecules that are able to inhibit the binding between ngf and the trka receptor as analgesics with prolonged effect
10/01/2008CN101277717A PCV-2 vaccine
10/01/2008CN101277716A Antibodies for the treatment of cancers
10/01/2008CN101277612A Composition and method for use in cartilage affecting conditions
10/01/2008CN101275143A Nucleic acid encoding hyaluronan synthase and methods of use
10/01/2008CN101275142A Newcastle disease virus infectious clones, vaccines and diagnostic assays
10/01/2008CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same
10/01/2008CN101274963A Anti-CD86 humanized monoclonal antibody
10/01/2008CN101274962A Antibodies against human IL-12
10/01/2008CN101274960A Genes associated with leishmania parasite virulence
10/01/2008CN101274959A Proteinase k resistant surface protein of neisseria meningitidis
10/01/2008CN101274957A Human cytomegalovirus M epitope and application thereof to medical research field
10/01/2008CN101274098A Treatment with anti-VEGF antibodies
10/01/2008CN101274097A Atomizing grippe vaccine composition and preparation thereof
10/01/2008CN101273995A Method for preparing magnetic particles modified by afi-tiazin dyes and application
10/01/2008CN100422332C Expression and export of angiostation and endostatin as immunofusins
10/01/2008CN100422328C Glycorpotein antigen SIMA135 expressed in metastatic human tumor cells
10/01/2008CN100422326C Si RNA capable of controlling foot-and-mouth disease virus copying and infection and its preparing method and use
10/01/2008CN100422322C Foot and mouth disease virus vaccine
10/01/2008CN100422316C Neutralizing human anti-IGFR antibody
10/01/2008CN100422213C Therapeutic binding molecules
10/01/2008CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same
10/01/2008CN100422210C Recombinant protective protein from streptococcus pneumoniae
10/01/2008CN100421730C Immunogenic composition
10/01/2008CN100421727C Methods
10/01/2008CN100421665C Mitotic kinesin inhibitors
10/01/2008CN100421661C Method of inducing cancer cell death and tumor regression
09/2008
09/30/2008US7429656 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
09/30/2008US7429653 Stabilized soluble glycoprotein trimers
09/30/2008US7429652 Expression vector comprising nucleotide sequences coding non-single-chain antigen-binding units for use in generating immunoglobulins for diagnosing and treating human disease
09/30/2008US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use
09/30/2008US7429646 Monoclonal, polyclonal, chimeric, humanize, fv, and or fab antibodies; hybridomas; vaccines; genetic engineering; isolated nucleic acids encoding a human TR2 receptor and two splice variants; medical diagnosis
09/30/2008US7429645 Humanized anti-lymphotoxin beta receptor antibodies
09/30/2008US7429644 Comprises lymphotoxin beta receptor (LT-BETA-R) immunoglobulin for treatment of tumor disorders
09/30/2008US7429643 POSH nucleic acids, polypeptides and related methods
09/30/2008US7429486 Recombinant production of mixtures of antibodies
09/30/2008US7429461 Genetic products differentially expressed in tumors and use thereof
09/30/2008US7429458 Binding preferential protein or peptide in sample; obtain sample containing peptides or proteins, incubate with elastomeric compound, heat, separate and recover bound bioplymers
09/30/2008US7429452 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein
09/30/2008US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections
09/30/2008US7429388 Vaccine for nontypeable Haemophilus influenzae infection
09/30/2008US7429387 Administering neurotoxin
1 ... 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 ... 1823